Annual D&A
$0.00
-$1000.00-100.00%
31 December 2023
Summary:
XTL Biopharmaceuticals annual depreciation & amortization is currently $0.00, with the most recent change of -$1000.00 (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$1000.00 (-100.00%). XTLB annual D&A is now -100.00% below its all-time high of $440.00 thousand, reached on 31 December 2003.XTLB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly depreciation & amortization is not available.XTLB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals TTM depreciation & amortization is not available.XTLB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | - | - |
| 3 y3 years | -100.0% | - | - |
| 5 y5 years | 0.0% | - | - |
XTLB Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | |||||
| 5 y | 5 years | -100.0% | |||||
| alltime | all time | -100.0% |
XTL Biopharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(-100.0%) | - | - |
| Dec 2022 | $1000.00(0.0%) | - | - |
| Dec 2021 | $1000.00(0.0%) | - | - |
| Dec 2020 | $1000.00(>+9900.0%) | - | - |
| Dec 2019 | $0.00(0.0%) | - | - |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00(-100.0%) | - | - |
| Dec 2015 | $7000.00(-86.8%) | - | - |
| Dec 2014 | $53.00 K(-83.1%) | $10.00 K(-9.1%) | $53.00 K(-56.6%) |
| Sept 2014 | - | $11.00 K(-8.3%) | $122.00 K(-35.1%) |
| June 2014 | - | $12.00 K(-40.0%) | $188.00 K(-26.3%) |
| Mar 2014 | - | $20.00 K(-74.7%) | $255.00 K(-18.5%) |
| Dec 2013 | $313.00 K(+130.1%) | $79.00 K(+2.6%) | $313.00 K(-0.6%) |
| Sept 2013 | - | $77.00 K(-2.5%) | $315.00 K(+8.2%) |
| June 2013 | - | $79.00 K(+1.3%) | $291.00 K(+36.6%) |
| Mar 2013 | - | $78.00 K(-3.7%) | $213.00 K(+56.6%) |
| Dec 2012 | $136.00 K | $81.00 K(+52.8%) | $136.00 K(+86.3%) |
| Sept 2012 | - | $53.00 K(+5200.0%) | $73.00 K(+62.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $1000.00(0.0%) | $45.00 K(-35.7%) |
| Mar 2012 | - | $1000.00(-94.4%) | $70.00 K(-25.5%) |
| Dec 2011 | $94.00 K(+623.1%) | $18.00 K(-28.0%) | $94.00 K(+23.7%) |
| Sept 2011 | - | $25.00 K(-3.8%) | $76.00 K(+24.6%) |
| June 2011 | - | $26.00 K(+4.0%) | $61.00 K(+60.5%) |
| Mar 2011 | - | $25.00 K(+150.0%) | $38.00 K(+123.5%) |
| Sept 2010 | - | $10.00 K(+233.3%) | $17.00 K(+70.0%) |
| June 2010 | - | $3000.00(0.0%) | $10.00 K(-9.1%) |
| Mar 2010 | - | $3000.00(+200.0%) | $11.00 K(-15.4%) |
| Dec 2009 | $13.00 K(-66.7%) | $1000.00(-66.7%) | $13.00 K(+8.3%) |
| Sept 2009 | - | $3000.00(-25.0%) | $12.00 K(+33.3%) |
| June 2009 | - | $4000.00(-20.0%) | $9000.00(+80.0%) |
| Mar 2009 | - | $5000.00 | $5000.00 |
| Dec 2008 | $39.00 K(-63.9%) | - | - |
| Dec 2007 | $108.00 K(-55.6%) | - | - |
| Dec 2006 | $243.00 K(+0.4%) | - | - |
| Dec 2005 | $242.00 K(-24.1%) | - | - |
| Dec 2004 | $319.00 K(-27.5%) | - | - |
| Dec 2003 | $440.00 K | - | - |
FAQ
- What is XTL Biopharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual D&A year-on-year change?
- What is the all time high quarterly D&A for XTL Biopharmaceuticals?
- What is the all time high TTM D&A for XTL Biopharmaceuticals?
What is XTL Biopharmaceuticals annual depreciation & amortization?
The current annual D&A of XTLB is $0.00
What is the all time high annual D&A for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual depreciation & amortization is $440.00 K
What is XTL Biopharmaceuticals annual D&A year-on-year change?
Over the past year, XTLB annual depreciation & amortization has changed by -$1000.00 (-100.00%)
What is the all time high quarterly D&A for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly depreciation & amortization is $81.00 K
What is the all time high TTM D&A for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM depreciation & amortization is $315.00 K